The first of a new type of COVID vaccine has been approved by the medical regulator for use in the UK.

The jab, made by US firm Novavax, is based on protein rather than genetic material from the virus.

The UK Vaccine Taskforce placed an order for 60 million doses in 2020, and the government had originally expected they would be available in the second half of 2021.

Please use Chrome browser for a more accessible video player

But the vaccine has been delayed by manufacturing problems and the regulatory process – and jabs from Pfizer, Moderna and Astra-Zeneca have since become the backbone of the UK rollout.

The delay caused problems for more than 15,000 people in the UK who volunteered for clinical trials of the jab.

They were unable to travel because many countries required proof of immunisation with a vaccine that had been approved by medical authorities.

The government announced last October that the volunteers would be given ‘top-up’ doses with the Pfizer jab so they could qualify for a vaccine pass abroad.

‘Kids were just giving up’: Clubs hope Winter Olympics will revive interest in ice sports as they struggle to recover from lockdowns

Winter Olympics athlete moved from COVID isolation facility after tearful plea for help

COVID-19: Despite Wednesday’s high figure, deaths may have peaked

The Novavax vaccine has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in adults over the age of 18.

Stanley Erck, President and Chief Executive Officer of the company, said: “We are proud that Nuvaxovid will be the first protein-based vaccine option authorised by the MHRA as the United Kingdom tackles this next phase of the pandemic.

“We thank the agency for its thorough review process and are tremendously grateful to the clinical trial participants and trial sites in the UK, as well as the Vaccine Taskforce, for their ongoing support and vital contributions to this program.”

Related posts:

UK records another drop in COVID infections as number of first jabs hits 22.2 million Boy, 17, killed after ‘metal pole touched electrical line’ in Lancashire Will the 21 June final stage of lockdown easing go ahead? Here’s what the data says Delay to 21 June reopening will be ‘death knell’ for night-time economy Murder of unidentified headless torso remains unsolved 30 years on Bailiffs start removing environmental protesters from trees and tunnels at HS2 site Big Ideas Live: Guide to the topics, speakers and timings Gangsters accused of providing real passports to criminal fugitives arrested in raids Dinosaur with uniquely ‘bulbous’ nose discovered on the Isle of Wight during lockdown Armistice Day: Nation falls silent to honour those who lost their lives in conflict Teens in England will be given extra help to prepare for their GCSEs and A-levels Ex-ambassador found dead in forest was suffering from ‘extreme stress’ while working on COVID taskforce, inquest told